Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

benign PEComa News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study published in PubMed examines the clinicopathological characteristics and surgical outcomes of primary hepatic perivascular epithelioid cell tumors (PEComas). This single-center cohort study provides valuable insights into the management of this rare tumor type.

A case report details the liquid-based cytologic features of a thyroid TFE3-rearranged PEComa-like neoplasm. This study contributes to the understanding of rare neoplasms and their cytological characteristics.

Not rare diseases news,news about your rare disease.

Earlier

A recent study published in PubMed examines the clinicopathological characteristics and surgical outcomes of primary hepatic perivascular epithelioid cell tumors (PEComas). This single-center cohort study provides valuable insights into the management of this rare tumor type.

A case report details the liquid-based cytologic features of a thyroid TFE3-rearranged PEComa-like neoplasm. This study contributes to the understanding of rare neoplasms and their cytological characteristics.

Not rare diseases news,
news about your rare disease.